ITOS - IBB: Healthcare Dashboard For April April, 18 2022 01:58 PM iTeos Therapeutics Inc. Pharmaceuticals and biotechnology still are attractive regarding value and quality. Other subsectors are overvalued by 15% to 42% relative to 11-year averages. Fast facts on IBB. 10 healthcare stocks cheaper than their peers in April. For further details see: IBB: Healthcare Dashboard For April